Drugs that contain Ertugliflozin

1. Steglatro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8080580 MERCK SHARP DOHME Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
Jul, 2030

(6 years from now)

Drug Exclusivity Drug Exclusivity Expiration
M (M) Sep 17, 2024

Market Authorisation Date: 19 December, 2017

Treatment: An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes


How can I launch a generic of STEGLATRO before it's drug patent expiration?
More Information on Dosage

STEGLATRO family patents

Family Patents